Providence Swedish Inflammatory Bowel Disease Conference 2025

+ Include: 17 Videos (.mp4) + 13 Audios (.mp3) + 13 Subtitles (.vtt), size: 8.75 GB
+ Target Audience: gastroenterologists and surgeons
+ Information:

1. Overview

The Providence Swedish Inflammatory Bowel Disease Conference 2025 explores the future of IBD care, emphasizing precision medicine and AI integration. The course covers advanced management strategies, including treatment de-escalation, nutritional therapy, and surgical interventions, alongside updates on IL-23 inhibitors and acute severe ulcerative colitis. Course Date: 2025

2. Learning Objectives

• Evaluate the progress toward precision medicine and the impact of AI on IBD clinical practice.

• Implement strategies for treatment de-escalation and treat-to-target monitoring.

• Manage nutritional therapy, pain, and opioid de-escalation in patients with ulcerative colitis.

• Discuss surgical options for UC and the management of intra-abdominal abscesses in Crohn’s disease.

• Review the latest updates from DDW 2025 and positioning therapies for UC.

3. Target Audience

Best for gastroenterologists and surgeons who want updates on precision medicine, surgical interventions, and emerging IBD therapies.

4. Topics

1. The Future of IBD Care – How Close are We to Precision Medicine (2025 Update)

2. If it Ain’t Broke, Don’t Fix It – Treatment De-Escalation in IBD

3. Monitoring Patients on IBD Therapy and Treat-to-Target

4. Nutritional Therapy and Pain Management in IBD

5. Q&A – Getting Patient Buy-in for Opiate De-escalation, Leniency with Medication Adherence in Patients with Moderate UC

6. The Role of Surgery in Ulcerative Colitis Care

7. Are All IL-23 Inhibitors the Same

8. Management of Acute Severe UC

9. The Management of Intra-Abdominal Abscesses in Crohn’s Disease

10. Will AI Put Us Out of (IBD) Business

11. Positioning Therapies for UC in 2025

12. Have We Made Progress in the Management of Cholestatic Liver Disease

13. IBD Updates from DDW 2025